Data Foundry

Medical device recalls 2019

BD FACSLyric Flow Cytometer — Class II medical device recall Z-0073-2020

Terminated recall by Becton, Dickinson and Company, BD Biosciences, reported 2019-10-16, distributed in CA, CO, FL, GA, HI, IA, IL, IN…. Flow cytometers, when used with specific tubes may experience excessive electronic abort counts (electronic ab

Recall numberZ-0073-2020
Product typeMedical device
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmBecton, Dickinson and Company, BD Biosciences, San Jose, CA, United States
Recall initiated2019-08-19
Classified2019-10-09
Reported by FDA2019-10-16
Terminated2024-04-12
DistributedCA, CO, FL, GA, HI, IA, IL, IN, KS, MA, MD, MI, MN, MO, NE, NJ, NY, OH, OK, PA, RI, TN, TX, VA, VT, WA
Countries outside the USAT, AU, BE, BR, CA, CH, CO, CZ, DE, DK, DZ, EC, ES, FI, FR, GB, HR, ID, IE, IL, IN, IQ, IR, IT, JP, KR, LT, LV, MX, MY, NL, PE, PL, QA, SA, SE, SG, SK, TR, TW, VN, ZA
Quantity236
Reason classespotency
UPC / GTIN / UDI-DI00658180000282, 00659180000234, 00659180000241, 00659180000258, 00659180000265, 00659180000272, 00659180000289, 00659180000296, 00659180000302, 00659180000319, 00659180000326, 00659180000333, 00659180000340, 00659180000357, 00659180000364, 00659180000371, 00659180000388, 00659180000395, 00659180000418, 00659180000425, 00659180000432
Serial numbers0000001R6591800, 9180000057, 9180000219, 9180000283, R658180000282, R6591800000082, R6591800000083, R659180000045, R659180000051, R659180000061, R659180000063, R659180000064, R659180000068, R659180000071, R659180000075, R659180000089, R659180000099, R659180000137, R659180000164, R659180000167, R659180000196, R659180000202, R659180000204, R659180000211, R659180000213 and 211 more
Model numbers659180, 65918001

Product

BD FACSLyric Flow Cytometer,3-Laser 10 Color Instrument, REF: 659180 and 65918001, when using BD Trucount Tubes

Reason for recall

Flow cytometers, when used with specific tubes may experience excessive electronic abort counts (electronic abort count of beads exceeds 1.0% of the total processed events), which may affect the ratio of cell population events to bead events, potentially resulting in falsely high absolute counts. This may affect the following: initiation of prophylactic therapy for Opportunistic Infections (HIV patients), decisions regarding care/management (PID/immune suppressed patients), laboratory developed tests/experiments, specimen engraftment potency, and use of leucoreduced blood products for transfusion.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0073-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.